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MHC-I epitope presentation to CD8+ T cells is directly dependent
on peptide loading and selection during antigen processing. How-
ever, the exact molecular bases underlying peptide selection and
binding by MHC-I remain largely unknown. Within the peptide-
loading complex, the peptide editor tapasin is key to the selec-
tion of MHC-I–bound peptides. Here, we have determined an en-
semble of crystal structures of MHC-I in complex with the peptide
exchange-associated dipeptide GL, as well as the tapasin-associated
scoop loop, alone or in combination with candidate epitopes.
These results combined with mutation analyses allow us to pro-
pose a molecular model underlying MHC-I peptide selection by
tapasin. The N termini of bound peptides most probably bind first
in the N-terminal and middle region of the MHC-I peptide binding
cleft, upon which the peptide C termini are tested for their capac-
ity to dislodge the tapasin scoop loop from the F pocket of the
MHC-I cleft. Our results also indicate important differences in pep-
tide selection between different MHC-I alleles.
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Peptide presentation by major histocompatibility class I(MHC-I) molecules is essential for recognition of intracel-
lular pathogens and malignancies (1–6). Following their transfer
by the transporter associated with antigen processing (TAP) into
the endoplasmic reticulum (ER), peptides are selectively loaded
on MHC-I with the help of the peptide loading complex (PLC)
multiprotein machinery, which consists of tapasin, ERp57, and
calreticulin (7). Until recently, the interactions of some of these
proteins, especially tapasin, with MHC-I/peptide (pMHC) com-
plexes have been mainly deduced from mutational and functional
studies. However, a recent low-resolution cryo-EM structure
revealed the spatial arrangement of tapasin and MHC-I molecules
within the PLC (8). Furthermore, two low-resolution crystal
structures (3.3 and 3.5 Å resolution, respectively) provided in-
sights into binding and interactions between MHC-I and the
tapasin homolog TAP-binding protein-related (TAPBPR) (9,
10). Thomas and Tampé described the presence of a “jack
hairpin” that lodges in under the MHC-I peptide binding cleft
and of a “scoop loop” that interacts with the C-terminal part of
the MHC-I peptide binding cleft (9). The N-terminal domain of
TAPBPR envelops the α2 helix and stabilizes the open con-
former of MHC-I molecules (9, 10), in a similar manner to how
HLA-DM interacts with peptide-empty MHC class II molecules
(MHC-II) (11). However, it should be noted that the overall
sequence identity between tapasin and TAPBPR is only 22%
(12). Importantly, the sequences of the scoop loops are also very
different in tapasin compared with TAPBPR. Furthermore, in
contrast to tapasin, TAPBPR does not bind ERp57 nor calreticulin
and is not an integral component of the PLC (13). Altogether, these
structural results indicate a potential key role in peptide editing
for both the scoop loop and the jack hairpin. It should however
also be noted that a large amount of additional contacts is
formed between TAPBPR and the peptide binding cleft, the α3
domain, and the β2m subunit of MHC-I alleles (9, 10), which
may also play a key role in sensing the presence of peptides with
adequate binding affinity.
In MHC-II antigen processing and presentation, the peptide-
editing HLA-DM has been previously mentioned as equivalent
to tapasin (14). A series of studies conducted by the Rötzschke
research group demonstrated that small organic compounds and
small peptides, usually dipeptides, can act similarly to HLA-DM,
resulting in the stabilization of peptide-receptive MHC-II mol-
ecules (15–17). A similar system has also been characterized for
MHC-I, demonstrating that dipeptides, including the dipeptide
GL, can act as both stabilizers of peptide-empty MHC-I mole-
cules and peptide exchange catalysts (18, 19).
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Here, we determined a suite of crystal structures of MHC-I
molecules that provide insights in the molecular basis underlying
peptide binding and selection by tapasin. Mutation studies
revealed the importance of specific residues within the scoop
loop of tapasin, with significant differences for selection between
different MHC-I alleles. Altogether, our results indicate that
candidate epitopes most probably bind first with their N termini
to the MHC-I peptide binding cleft before being tested for their
capacity to dislodge the tapasin scoop loop from the F pocket of
MHC-I molecules.
Results and Discussion
We initiated the present study by determining the crystal struc-
ture of the murine MHC-I allele H-2Kb in complex with the
dipeptide GL to 1.8-Å resolution (SI Appendix, Table S1). The
unbiased electron density revealed that the peptide loading cleft
was mainly empty, besides very few water molecules, most lo-
calized in the vicinity of the F pocket. Clear density allowed for
unambiguous modeling of the GL dipeptide within the F pocket
(Fig. 1 A and B). Importantly, the peptide binding cleft of H-2Kb/GL
takes a nearly identical conformation compared with classical
pMHC complexes such as H-2Kb bound to the Sendai virus-
derived epitope SEV (FAPGNYPAL) (20), indicating that GL
stabilization of the F pocket is enough to keep the peptide
binding cleft in the same conformation as when a full-length
peptide is bound (Fig. 1C). Thus, binding of GL renders the
MHC-I cleft fully available for peptide binding and selection and
does not result in any widening of the C-terminal section of the
peptide cleft as described in the structures of the TAPBPR/
MHC-I complex (9, 10). Several hydrogen bonds are formed
between GL and the heavy chain residues D77, Y84, T143, K146,
and W147, as well as three water molecules (Fig. 1D). It should
also be noted that the omit map demonstrates that the side chain
of the MHC-I residue Y84 is pointing toward the peptide binding
cleft, forming two hydrogen bonds with the C terminus of GL
(Fig. 1D).
We thereafter assessed if the GL dipeptide is present in any of
the PLC protein components and, indeed, found that a GL se-
quence is indeed localized at the tip of a disordered loop in
tapasin (SI Appendix, Fig. S1), which is not visible in the pre-
viously determined crystal structure of tapasin (21). The 5.8-Å
cryo-EM analysis of the peptide loading complex indicated that
this tapasin loop could be located close to the F pocket of MHC-
I molecules (8). Hypothesizing that GL can bind simultaneously
with other peptides, we refolded H-2Db with both GL and a C-
terminally truncated version of SEV corresponding to the stretch of
residues FAPGNYP (FP7). The crystal structure of the H-2Db/FP7/
GL complex, determined to 2.3 Å, revealed that both GL
and FP7 bound simultaneously to the MHC-I cleft. The di-
peptide GL occupies the F pocket similarly to the H-2Kb/GL
complex, while FP7 stretches throughout the peptide binding
cleft (Fig. 2 A–C), with peptide residues p1–p5 taking the same
conformation as in the crystal structure of H-2Db in complex
with the full-length SEV peptide (FAPGNYPAL) (22). In con-
trast, residues p6Y and p7P take significantly different confor-
mations compared with the full-length SEV peptide (Fig. 2D).
Thus, our structural analysis suggests that the N-terminal part of
an MHC-I–restricted peptide possibly binds first to the peptide
binding cleft while the C-terminal part is tested for its capacity to
potentially dislodge the GL dipeptide, part of the tapasin loop,
from the F pocket.
Next, we investigated if an MHC-I molecule could be refolded
simultaneously with the tapasin scoop loop and the trun-
cated peptide FP7. The crystal structure of H-2Db in complex
with both the mouse tapasin-associated loop-derived TL10
(EDAGGGGLSK) and the peptide FP7 was determined to 2.15
Å (Fig. 3 A, B and C). The p1–p5 section of FP7 takes a con-
formation identical to that in H-2Db/FP7/GL (Fig. 3D). The
flexibility of TL10 due to a large number of glycine residues
allowed us to unambiguously define the exact conformation of
only the five C-terminal residues of this tapasin-derived loop,
including the leucine residue that clearly occupies the F pocket
(Fig. 3 A–C). Thus, the GL tip of TL10 binds similarly to the
dipeptide GL within the MHC-I F pocket while the remaining
part of this loop protrudes out toward the solvent (Fig. 3D).
Here again, while it has been demonstrated that the C-terminal
part of MHC-I molecules widens upon binding to TAPBPR (9,
10), simultaneous binding of the tapasin-associated TL10 and the
truncated peptide FP7 does not affect the conformation of the α1
and α2 helices, compared with the crystal structure of the same
MHC-I molecule in complex with the full-length epitope SEV
(Fig. 3 E and F). Furthermore, in the TAPBPR structures, at-
tention was drawn to the positioning of the MHC-I heavy chain
residue Y84, the side chain of which rotated away from the
peptide binding cleft to interact with the TAPBPR residue E105
(SI Appendix, Fig. S2). The asymmetric unit of the TAPBPR
comprises four complexes, two of which have the side chain of
Y84 pointing as described in this previous report toward
TAPBPR. However, it should be noted that the side chain of
Y84 still points toward the peptide binding cleft of the MHC
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Fig. 1. The GL dipeptide binds within the MHC-I F pocket, resulting in a
peptide-receptive conformation. (A) The 2FoFc omit map drawn at 1σ level
reveals unambiguous electron density for the GL dipeptide within the F
pocket of the H-2Kb peptide binding cleft. The omit map, in blue, also allows
for unambiguous positioning of all of the side chains of the MHC-I peptide
binding cleft. For clarity, only the omit map for the side chains of MHC
residues comprising the helices is displayed. The omit map for MHC-I residues
that are localized at the bottom of the peptide binding cleft is not displayed.
The side chains of the MHC heavy chain residues are not displayed either. A
few water molecules (red balls) are mostly grouped around the C-terminal
part of the peptide binding cleft. (B) Surface representation of the peptide-
binding cleft reveals that it is empty with three water molecules surrounding
the GL dipeptide that binds in the F pocket. (C) The peptide binding cleft of
the H-2Kb/GL complex, in white, takes the same conformation as in H-2Kb in
complex with the full-length prototypic peptide SEV (FAPGNYPAL), in gray.
No widening of the cleft is observed. (D) The side chain of the leucine residue
in the GL dipeptide anchors in the F pocket while several hydrogen bonds
(dashed lines) are formed between the COO− terminal of the dipeptide and
the MHC-I residues Y84, T143, and K146. Additional hydrogen bonds are
formed between the backbone of the dipeptide and three water molecules
as well as the MHC-I residues D77 and W147.
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allele in the two other complexes within the same asymmetric
unit (PDB ID code 5WER).
It is well established that residue Y84 forms two essential
hydrogen bonds with the terminal COO− group of any MHC-I–
bound prototypic full-length peptide (23, 24). Here, in contrast
to the TAPBPR structures, the crystal structure of the tapasin-
derived TL10 scoop loop in complex with MHC-I keeps the same
conformation for residue Y84 as in all known MHC/full-length
peptide complexes. In contrast to the TAPBPR/MHC-I struc-
tures, the side chain of Y84 forms hydrogen bonds with the
backbone of TL10 (PDB ID codes 5OPI and 5WER) (9, 10)
(Fig. 3 and SI Appendix, Fig. S2). It should also be noted that
since the scoop loop of TAPBPR comprises an α-helical segment,
which dives toward the F pocket, it could provide a certain level of
rigidity resulting in the widening of the MHC peptide binding
cleft, while the scoop loop of tapasin should be more flexible due
to the presence of a larger amount of glycine residue. It should
therefore not be able to influence the structure of the MHC
peptide binding cleft as much as observed for TAPBPR.
There are several possible explanations for this dichotomy
between our and others’ results regarding both the widening of
the cleft and the rotation of the side chain of Y84 observed in the
structures of TAPBPR in complex with pMHC molecules.
Binding of the FP7 fragment at the N-terminal section of the
peptide binding cleft, as revealed by the crystal structure of the
H-2Db/FP7/GL complex, could be enough for the C-terminal
part of the MHC-I cleft to take a conformation similar to the
final MHC-I/peptide product. However, in this case, we should
also have observed a movement of the α2 helix in the crystal
structure of the H-2Kb/GL complex, which was not the case. A
second possibility could be that only the jack-hairpin in both
tapasin and TAPBPR is responsible for this observed movement
of the α2 helix, and that since we only have the scoop loop in our
structures, the conformations of our pMHC are not affected.
One possible consequence of this widening is that it could fa-
cilitate for the C-terminal section of the full-length peptide to
reach within the F pocket and compete with the GL tip of the
scoop loop. Finally, a third possibility is that TAPBPR and
tapasin do not make use of equivalent molecular approaches to
select MHC-I–restricted peptides.
To investigate if the flexible tapasin loop is essential for the cell
surface expression of pMHC complexes, tapasin was knocked out
in MEF cells and constructs containing mutated or truncated
versions of tapasin were transduced into these cells. The cell
surface expression levels of H-2Db and H-2Kb were thereafter
assessed using flow cytometry (Fig. 4). The intracellular expression
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Fig. 3. The tapasin scoop loop-derived TL10 binds to the MHC-I F pocket. (A)
The omit map for the H-2Db/FP7/TL10 complex, displayed at 1σ, reveals that
the truncated version of the SEV epitope, FP7 (FAPGNYP; in yellow), and the
tapasin scoop loop TL10 (EDAGGGGLSK; in magenta) bind simultaneously to
the MHC-I cleft. The side chain of the key leucine residue in TL10 is buried
within the MHC-I F pocket. The quality of the electron density allowed for
unambiguous positioning of the five residues GGLSK while the rest of TL10 is
highly flexible. (B) Surface representation of the H-2Db/FP7/TL10 complex
with both the FP7 and TL10 peptides displayed as sticks reveal how the two
epitopes occupy the peptide binding cleft of H-2Db. (C) Side view of FP7 and
TL10 reveals simultaneous occupancy of the peptide binding cleft. (D) The
truncated peptide FP7 takes the same conformation in H-2Db/FP7/TL10 as in
the H-2Db/FP7/GL complex. The side chain of the leucine residue in TL10
takes a similar conformation within the F pocket as for the GL dipeptide in
both H-2Db/FP7/GL and H-2Kb/GL, in white and purple, respectively. (E) The
peptide binding cleft in H-2Db/FP7/TL10 (in cyan) takes a similar conforma-
tion to H-2Db in complex with the full-length peptide SEV (in white). (F) In
contrast to the structure of TAPBPR/pMHC-I (in orange), there is no widening
of the C-terminal part of the cleft (in cyan) in H-2Db/FP7/TL10. The rigid
TAPBPR α-helical scoop loop is displayed in light brown.
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Fig. 2. A truncated version of SEV binds simultaneously with GL to the
MHC-I peptide binding cleft. (A) The omit map for the H-2Db/FP7/GL com-
plex, displayed at 1σ, reveals that the truncated version of the SEV epitope,
FP7 (FAPGNYP), and the dipeptide GL bind simultaneously to the MHC-I cleft.
(B) Surface representation of H-2Db with the two peptides displayed as sticks
reveals how FP7 (in yellow) stretches throughout the peptide binding cleft,
while GL (in magenta) binds to the F pocket. (C) Simultaneous binding of the
FP7 and GL peptides (in yellow and magenta, respectively) does not affect
the conformation of the dipeptide compared with H-2Kb/GL (in white). (D)
Superposition of the H-2Db/FP7/GL crystal structure on the crystal structure
of H-2Db in complex with the full-length SEV peptide reveals that the five N-
terminal residues in FP7 (in yellow) take the same conformations as the
corresponding stretch of residues in the full-length peptide SEV (in light
blue). In contrast, the side chains of residues p6Y and p7P in FP7 take dif-
ferent conformations compared with SEV, protruding out toward the sol-
vent. The dipeptide GL in H-2Db/FP7/GL (in magenta) binds exactly as the two
C-terminal residues p8A and p9L in SEV.
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levels of transduced tapasin were also verified by Western blot
and confocal microscopy (SI Appendix, Fig. S3). While expres-
sion levels of some tapasin variants were reduced, other vari-
ants were expressed at similar levels compared with wild-type
tapasin. Thus, our results demonstrate that mutation and/or
removal of several residues within this loop drastically reduces
the expression levels of both MHC-I alleles. Interestingly, while
single mutation of the leucine residue reduced significantly the
cell surface expression levels of H-2Kb, H-2Db expression levels
remained less affected. This indicates that the peptide loading
and selection mechanisms steered by tapasin are most probably
different with different MHC-I alleles. These results also sug-
gest that the selection stringency based on the capacity of
peptides to dislodge the loop from the F pocket is different
from MHC-I allele to allele.
Previous studies of specific tapasin-dependent and tapasin-
independent MHC class I alleles such as HLA-B4402/HLA-
B4405, as well as HLA-B2705/HLA-B2709, respectively, revealed
the key role of residue 116, which is the only residue that differs
between these alleles, for tapasin dependence (25–27). It has also
previously been suggested that the identity of residue 116 may re-
sult in increased or reduced conformational disorder within the F
pocket, resulting in possible higher tapasin dependence for MHC-I
alleles with higher conformational disorder. In the same study, the
authors demonstrated that they could reduce conformational in-
stability by mutating residue 116 and improve its interactions with
residue 114, as well as reduce significantly the dependence of the
substituted MHC-I allele for tapasin (28). The identity of residue
116 differs also between H-2Kb and H-2Db (Y and F, respectively).
However, the much larger amount of residues that differ between
these twoMHC-I alleles impairs our ability to conclude that residue
116 here again may alone account for tapasin dependence or in-
dependence (SI Appendix, Fig. S4).
Our mutational studies also indicate strong differences in how
tapasin may select, with different levels of stringency, for epi-
topes that bind to different MHC alleles. Indeed, while single
scoop loop mutations reduced significantly the cell surface expres-
sion levels of H-2Kb/peptide complexes, the levels of H-2Db/pep-
tide complexes were affected only after deletion of a large
section of the tapasin loop. Thus, this result could provide an
important molecular insight into the possible promiscuity or
stringency of the peptide repertoire selection in different MHC-I
alleles. Indeed, our results demonstrate that deletion and/or
mutation of the leucine residue affects significantly the cell
surface expression levels of H-2Kb complexes, while H-2Db cell
expression levels are significantly reduced only after the deletion
of at least six residues in the scoop loop (Fig. 4).
As mentioned above, the sequence of the TAPBPR scoop
loop is very different compared with tapasin. While the tip of the
TAPBPR scoop loop comprises the stretch of residue ASSE, the
corresponding loop in mouse tapasin is composed of GGLS
(KGLA in human), most probably providing substantial differ-
ences in mobility and charge. Neither of the two previously
published tapasin structures provides any information about the
position of the key section of the scoop loop corresponding to
TL10 (8, 21). Indeed, in the crystal structure of tapasin in
complex with ERp57, this loop is not visible in the density and
cannot be modeled (SI Appendix, Fig. S1) (21). This 3D model
was also used as a template in the low-resolution cryo-EM
structure of the PLC (8). Thus, as such, the previously pub-
lished structural results do not provide any conclusive evidence
for the positioning of this loop. It is however stated by Blees et al.
(8) that the N-terminal β-barrel of tapasin appears very mobile in
the PLC structure (SI Appendix, Fig. S5), meaning that the
mobility of this section, including the scoop loop, extends well
beyond the loop itself. Keeping this in mind, the much more
flexible glycine-rich tapasin scoop loop cannot include a helical
segment as found in TAPBPR, which provokes the widening of
the binding groove. Instead our molecular model indicates that
the GL tip of the tapasin scoop loop (G17-L18) can come close
and bind into the F pocket (SI Appendix, Figs. S1 and S5).
Based on the results presented within this study as well as
results from others (9), we here propose a hypothetical model
underlying peptide loading mechanisms and selection for MHC-I
molecules (Fig. 5). Our results do not provide any evidence for a
widening of the peptide binding cleft of MHC-I molecules fol-
lowing binding to the tapasin-derived scoop loop TL10. Fur-
thermore, the crystal structure of H-2Kb in complex with the
dipeptide GL certainly demonstrates that no widening of the C-
terminal part of the peptide binding cleft takes place when GL
binds to the F pocket. However, this hypothesis needs to be
confirmed by further structural studies involving the entire
tapasin molecule and different MHC-I alleles. Altogether, our
results demonstrate that the tapasin loop TL10 can bind to the F
pocket, using the leucine residue as an anchor and, thereby,
stabilize the peptide binding cleft. Possibly, the presence of a jack
hairpin loop underneath the MHC-I peptide binding cleft may
widen the C-terminal section, facilitating access for the C-terminal
section of candidate epitopes to try to dislodge the GL tip of the
scoop loop. The possible importance of a large amount of contacts
formed between TAPBPR and MHC-I molecules for peptide
editing cannot be excluded either. However, based on the analyses
of our high-resolution crystal structures, our present hypothesis is
that full-length peptides bind to specific MHC-I alleles with their
N-terminal part binding first into the N-terminal part of the
MHC-I peptide binding cleft, before being tested for their ca-
pacity to dislodge the tapasin loop from the F pocket and form the
final MHC/peptide complexes (Fig. 5).
One possible explanation for these results is that the tapasin
loop can be more easily dislodged in H-2Db compared with H-
2Kb, resulting in the presentation of a broader repertoire of
peptides, including possibly a larger array of relatively lower-
affinity epitopes by H-2Db. Indeed, we were never able to ob-
tain crystals of the H-2Db/GL complex, possibly due to the fact
that the dipeptide dissociates easier from this allele compared
with H-2Kb. Furthermore, the binding motif requirements are
much more stringent for the N-terminal and middle sections of
H-2Db–restricted epitopes compared with H-2Kb with much
stricter requirements for peptide positions 2 (M, S, A), 3 (I, M,
L, P, V) and most importantly position 5 (mostly N, possibly M)
Fig. 4. Mutation of the leucine residue in the tapasin scoop loop reduces
significantly H-2Kb cell surface expression levels. SPM43 MEF Tapasin-KO
cells, transduced with lentiviral vectors encoding for mouse wild-type
tapasin or mutated variants, were stained for cell surface expression of H-
2Db (Upper) and H-2Kb (Lower). The flow cytometry mean fluorescence in-
tensity (MFI) for each sample was normalized to the background MFI of
corresponding unstained sample. The experiment represents an average of
two independent experiments in triplicates. Statistical analysis was calcu-
lated using one-way ANOVA. Asterisks indicate level of significance with
*P < 0.05; ****P < 0.0001. Deletion of the scoop loop abolished cell surface
expression levels of both H-2Db and H-2Kb. Mutation of the leucine residue
in the tapasin scoop loop reduced significantly the cell surface expression
levels of H-2Kb. In contrast, expression of H-2Db complexes was unaffected.
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(29, 30). Thus, a “stronger” and more stringent binding of the N-
terminal and middle section in epitopes specific to H-2Db could
also reduce the potential entropic cost required for dislodging
the tapasin loop compared with H-2Kb. In contrast, the more
promiscuous motif for N-terminal residues in H-2Kb may thus
require higher entropic cost for peptides to compete away the
scoop loop, resulting potentially in a more stringent selection of
adequate, often high-affinity, peptides.
Altogether, our results suggest that candidate epitopes may
bind first with their N termini to the MHC-I peptide binding cleft
before being tested for their capacity to dislodge the tapasin
scoop loop from the F pocket of MHC-I molecules. We propose
that the selection stringency based on the capacity of peptides to
dislodge the loop from the F pocket is different from MHC-I
allele to allele. This study together with recently published PLC
structure and crystal structures of tapasin homolog protein
TAPBPR could provide an important molecular insight into the
possible promiscuity or stringency of the peptide repertoire se-
lection in different MHC-I alleles. However, the impact of the
tapasin scoop loop on peptide repertoire of different MHC-I
alleles in health or disease has yet to be discovered.
Materials and Methods
Preparation and Crystallization of the MHC-I/Peptide Complexes. The GL pep-
tide was purchased from Bachem. FP7 (FAPGNYP) and TL10 (EDAGGGGLSK)
were prepared by microwave-assisted solid phase synthesis based on Fmoc
chemistry (31) on a CEM Liberty peptide synthesizer. Peptides were purified
by RP-HPLC on a Jasco BS-997-01 instrument equipped with a DENALI C-18
column from GRACE VYDAC (10 μm, 250 × 22 mm). Refolding and purifi-
cation of all pMHC complexes were performed as described (3, 32–34).
Refolding and purification of H-2Kb/GL and H-2Db/FP7/GL were performed in
the constant presence of 10 mM GL peptide.
Crystals for all pMHC complexes were obtained by using the hang-
ing drop vapor diffusion method. The best H-2Kb/GL diffracting crystal
appeared in pH 6.7, 2.15 M Na/K phosphate, 15% 2-Methyl-2,4-pentanediol
(MPD). Two microliters of H-2Kb/GL in 10 mM Tris·HCl (pH 7.5), 150 mM
NaCl, and 10 mM GL were mixed with 1 μL of well solution and equilibrated
against 1 mL of well solution at 4 °C. The best crystals for H-2Db/FP7/GL
appeared in 2 M ammonium sulfate, 0.1 M Tris·HCl (pH 7.5), and 0.5 M NaCl
at 4 °C. One microliter of 4 mg/mL protein solution in 10 mM Tris·HCl (pH
7.5), 150 mM NaCl, and 10 mM GL were mixed with 2 μL of crystallization
reservoir solution, and thereafter equilibrated against 1 mL of well solu-
tion at 4 °C. The best crystals for H-2Db/FP7/TL10 appeared in 1.8 M am-
monium sulfate, 0.1 M Tris·HCl (pH 8), and 0.5 M NaCl at 4 °C. Two
microliters of 3 mg/mL protein solution in 10 mM Tris·HCl (pH 7.5) and
150 mM NaCl were mixed with 2 μL of crystallization reservoir solution, and
thereafter equilibrated against 1 mL of well solution at 4 °C.
Data Collection and Processing. Data collection for all of the pMHC complexes
were performed under cryogenic conditions at both beam lines 14.1 (BESSY II)
and ID30-A/MASSIF-1 (ESRF). Crystals were soaked in a cryoprotectant solu-
tion containing 25% glycerol before freezing. For H-2Kb/GL a total of 360
images were collected with 0.5° oscillation per frame. For H-2Db/FP7/GL and
H-2Db/FP7/TL10, 2,000 and 1,800 images, respectively, were collected with
0.1° oscillation per frame. Data were processed with MOSFLM (35) and
AIMLESS (36) from the CCP4 suite. Crystals for both H-2Kb/GL and H-2Db/FP7/
TL10 belong to the P21 space group, while H-2Db/FP7/GL crystals belong to
the I2 space group. Data collection statistics are provided in SI Appendix,
Table S1.
Crystal structure determination and refinement. The crystal structures of H-2Db/FP7/
GL and H-2Db/FP7/TL10 were determined by molecular replacement using
Phaser (37) and the H-2Db/gp33 complex with the peptide omitted (PDB ID
code 1S7U) (3) as a search model. The Balbes automatic molecular replace-
ment service was used for H-2Kb/GL. For H-2Kb/GL and H-2Db/FP7/GL, two
complexes were found in each asymmetric unit, while for H-2Db/FP7/TL10,
four complexes were found. Five percent of the total amount of reflections
was set aside for monitoring refinement by Rfree. Refinement of the crystal
structure was performed using REFMAC (38) and Phenix (39). Unambiguous
electron densities were observed in the peptide-binding clefts of all three
pMHC complexes. Water molecules were added using COOT (40, 41) and
their positions inspected manually. The stereochemistry of the final models
was verified with COOT. Final refinement parameters are presented in SI
Appendix, Table S1. Figures were created using PyMOL (The PyMOL Mo-
lecular Graphics System, Version 1.8 Schrödinger, LLC).
MHC-I cell surface expression analyses. SPM43 Tapasin-KOMEF cells were grown
in DMEM, Glutamax supplemented with 10% FBS, and 1× Pen-Strep.
HEK293FT cells were cultured in DMEM, Glutamax supplemented with 10%
FBS, 1× nonessential amino acids, and 25 mM Hepes.
SPM43 Tapasin KO MEF cells were transduced with indicated Tapasin-iG2
Lentiviral particles (Fig. 4 and SI Appendix, Supplementary Materials and
Methods and Fig. S4) overnight in the presence of 4 μg/mL polybrene
H-2Kb/GL
H-2Db/FP7/GL
H-2Db/FP7/TL10
H-2Db/SEV
A
B
C
D
Fig. 5. Hypothetical molecular model underlying tapasin-mediated MHC-I
peptide selection and binding. Based on the results obtained within this
study, we propose the following hypothetical model for tapasin-mediated
epitope selection and binding. (A) The association of the GL tip of the
tapasin scoop loop (dark green) with peptide-empty MHC-I stabilizes the
pMHC complex. (B and C) The candidate peptide binds to the MHC-I cleft
first with its N terminus and can be released again if it displays insufficient
affinity. If the peptide N-terminal section displays sufficient affinity to the
cleft, the C-terminal part of the candidate peptide is tested for its capacity to
dislodge the scoop loop. (D) If the candidate epitope is successful in dis-
lodging the scoop loop, tapasin releases its grip from the cleft, and a full-
length complex is formed.
Hafstrand et al. PNAS | March 12, 2019 | vol. 116 | no. 11 | 5059
IM
M
U
N
O
LO
G
Y
A
N
D
IN
FL
A
M
M
A
TI
O
N
(Sigma-Aldrich). Transduction efficiency was checked on days 3 and 8 after
transduction by flow cytometry by assessing GFP percentage (over 90% for
all conditions). Tapasin expression was confirmed by Western Blot and
confocal microscopy (SI Appendix, Fig. S4). Cell surface MHC-I levels were
assessed by flow cytometry using anti-H-2Kb-PE (clone AF6-88.5; BioLegend)
and H-2Db-BV711 (clone KH95; BD) antibodies in triplicates. Data were an-
alyzed using FlowJo V.10.5. (FlowJo LLC). Statistical analysis was performed
using GraphPad Prism.
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